Major histocompatibility complex restriction between hematopoietic stem cells and stromal cells in vitro

Area of Science:

• Immunology
• Hematology
• Stem Cell Biology

Background:

• Previous findings indicated hematopoietic progenitor accumulation in engrafted bones sharing the same major histocompatibility complex (MHC) as transplanted cells.
• The microenvironment's role in hematopoietic stem cell (HSC) engraftment and the nature of MHC restriction require further elucidation.

Purpose of the Study:

• To investigate the MHC restriction between hematopoietic stem cells (HSCs) and their microenvironment.
• To determine the specific MHC molecules involved in mediating this restriction.
• To understand how MHC interactions influence stromal cell activity and cytokine production supporting hematopoiesis.

Main Methods:

• Cobblestone colony formation assays were performed by co-culturing HSCs with MHC-matched and MHC-mismatched stromal cell monolayers.
• Experiments utilized MHC class I-deficient HSCs and stromal cells to assess the role of MHC class I molecules.
• Monoclonal antibodies (mAbs) targeting MHC class Ia molecules on stromal cells and HSCs were used to modulate interactions.

Main Results:

• Significantly reduced cobblestone colony formation was observed with MHC-mismatched stromal cells compared to MHC-matched controls.
• This reduction was not significant when using MHC class I-deficient HSCs or stromal cells, implicating MHC class Ia molecules.
• Treatment with anti-MHC class Ia mAbs on stromal cells enhanced colony formation and cytokine expression, while similar treatment on HSCs inhibited it.

Conclusions:

• The study suggests that MHC preference in HSC-microenvironment interactions is restricted by MHC class Ia molecules.
• Signaling via MHC molecules enhances stromal cell activity and cytokine production, augmenting hematopoiesis.
• These findings elucidate a key mechanism of MHC restriction in the hematopoietic system.